New York (MedscapeWire) June 6 — Chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) prior to cystectomy may increase survival time in patients with locally advanced bladder ...
Dose-dense methotrexate plus vinblastine, doxorubicin, and cisplatin improved time to progression. Dose-dense methotrexate plus vinblastine, doxorubicin, and cisplatin (dd-MVAC) can improve outcomes ...
Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema: A Randomized Controlled Trial Our prospective randomized phase ...
Treatment for muscle-invasive bladder cancer called dose-dense MVAC did not improve survival compared with chemotherapy alone, although one drug in the combination faces a shortage. In some patients ...
Intravenous drip Neoadjuvant dd-MVAC improves overall and disease-specific survival vs gemcitabine-cisplatin in muscle-invasive bladder cancer, a phase 3 trial suggests. Dose-dense methotrexate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results